Related by context. All words. (Click for frequent words.) 73 satraplatin 70 Pirfenidone 69 Civacir 69 Amrubicin 68 Nexavar ® 67 Vectibix 67 Pfizer Sutent 67 Ambrisentan 67 Glufosfamide 67 Nexavar sorafenib 66 Erbitux cetuximab 66 Torisel 66 Erbitux 66 Taxotere ® 66 ixabepilone 66 axitinib 66 Ixempra 66 Pazopanib 66 Allovectin 7 66 Hycamtin 66 Irinotecan 66 Cimzia 66 Cethromycin 66 Velcade bortezomib 66 Vectibix panitumumab 66 Daclizumab 65 Taxotere docetaxel 65 Clofarabine 65 Vandetanib 65 Avastin bevacizumab 65 bevacizumab Avastin 65 aflibercept 65 ASA# 65 Boceprevir 65 Perifosine 65 Ceflatonin 65 Onco TCS 65 Treanda 65 Aflibercept 65 docetaxel Taxotere R 65 CoFactor 65 Maribavir 65 Pemetrexed 65 Cladribine 65 TEMODAL 65 Golimumab 65 perifosine 65 temsirolimus 65 FTY# 65 Telaprevir 65 Zalbin 64 Canvaxin 64 Corlux 64 Zarnestra 64 Noxafil 64 Bevacizumab 64 Icatibant 64 sorafenib Nexavar 64 Elesclomol 64 Herceptin trastuzumab 64 BAY #-# 64 Fodosine 64 Gemcitabine 64 YONDELIS 64 Actemra 64 Sanofi Aventis Taxotere 64 vemurafenib 64 R sorafenib tablets 64 Epratuzumab 64 Mycamine 64 amrubicin 64 Fusilev 64 Dapagliflozin 64 TREANDA 64 Zactima 64 Marqibo 64 ONGLYZA ™ 64 Investigational Compound 64 panitumumab 64 Pegintron 63 Abraxane 63 Junovan 63 Sorafenib 63 Peginterferon alfa 2b 63 Yondelis 63 Dasatinib 63 mapatumumab 63 T DM1 63 Alemtuzumab 63 Jevtana 63 Sprycel 63 OMP designation 63 carfilzomib 63 Erlotinib 63 Taxotere R 63 IgG1 monoclonal antibody 63 Celgene Revlimid 63 LymphoStat B 63 Orencia 63 Pixantrone 63 Febuxostat 63 YONDELIS R 63 ImClone Erbitux 63 L BLP# 63 Sebivo 63 Dendreon Provenge 63 LymphoStat B TM 63 Advexin 63 Onconase 63 Oxaliplatin 63 Revlimid 63 Phenoptin 63 Nexavar 63 sorafenib tablets 63 apaziquone 63 Laquinimod 63 Clevudine 63 SinuNase 63 Pivotal Phase III 63 Everolimus 63 Kuvan 63 Neuvenge 63 glufosfamide 63 orphan designation 62 ceftobiprole 62 NVA# 62 Arranon 62 Picoplatin 62 Firazyr 62 Folotyn 62 IRESSA 62 Carfilzomib 62 sunitinib malate 62 Arzerra 62 Humira adalimumab 62 AP# [003] 62 Xinlay 62 amifampridine phosphate 62 Mepact 62 Archexin 62 Votrient 62 Camptosar ® 62 Targretin 62 Raptiva ® 62 Roche Avastin 62 Rivaroxaban 62 Arimoclomol 62 CAELYX 62 Alimta pemetrexed 62 regorafenib 62 Tarceva 62 Promacta 62 UPLYSO 62 Marketing Authorisation Application 62 taxane 62 Gemzar ® 62 Zolinza 62 HuMax CD4 62 Lenalidomide 62 Onalta 62 Teysuno 62 registrational trial 62 Tarceva erlotinib 62 eltrombopag 62 ATryn R 62 CDP# 62 Mipomersen 62 talactoferrin 62 interferon gamma 1b 62 picoplatin 62 Ceftobiprole 62 Xarelto rivaroxaban 62 Ceplene 62 IL# PE#QQR 62 Campath 62 methylnaltrexone 62 Reverset 62 valopicitabine 62 NOXAFIL 62 Telavancin 62 daclizumab 62 PTK ZK 62 SAR# [004] 62 Gemzar 62 Bortezomib 62 Tasigna nilotinib 62 evaluating satraplatin 62 Merck KGaA Erbitux 62 Sutent sunitinib 62 Ustekinumab 62 docetaxel Taxotere ® 62 Troxatyl 62 thalidomide Thalomid 62 Temsirolimus 62 MyVax 62 proteasome inhibitor 61 ADVEXIN 61 oral ridaforolimus 61 mTOR inhibitor 61 Roche Xeloda 61 lorvotuzumab mertansine 61 ThermoDox R 61 Afinitor 61 Eribulin 61 Bayer Nexavar 61 Meets Primary Endpoint 61 Replagal 61 Orathecin 61 Dacogen 61 Tarceva TM 61 Voreloxin 61 Romiplostim 61 tolevamer 61 AVASTIN 61 MabCampath 61 Marketing Authorization Application 61 trastuzumab DM1 61 Cetrorelix 61 Onrigin 61 investigational humanized monoclonal antibody 61 ZOLINZA 61 LAF# 61 Safinamide 61 metastatic renal cell carcinoma 61 Bayer Onyx 61 vandetanib 61 Denufosol 61 Dacogen injection 61 vinflunine 61 Paclitaxel 61 Certican 61 ZACTIMA 61 BENLYSTA 61 Mylotarg 61 Medicinal Products EMEA 61 histone deacetylase HDAC inhibitor 61 Somatuline Autogel 61 Doxil 61 Gleevec imatinib mesylate 61 Phase III Trial 61 investigational compound 61 JAK inhibitor 61 Romidepsin 61 mertansine 61 VEGF Trap 61 Metastatic Colorectal Cancer 61 Docetaxel 61 FOLOTYN ® 61 Roflumilast 61 iniparib 61 OvaRex ® MAb 61 elotuzumab 61 anidulafungin 61 OPAXIO 61 IMGN# 61 Zybrestat 61 Firdapse 61 Lacosamide 61 Pruvel 61 Fludara ® 61 Tocosol Paclitaxel 61 Esbriet 61 AZILECT R 61 MAGE A3 ASCI 61 TYZEKA 61 ORENCIA ® 61 Gefitinib 61 ASONEP 61 Virulizin R 61 Evoltra 61 Panzem R NCD 61 Clolar 61 IMiDs R 61 Campath ® 61 PrevOnco 61 Rituximab 61 SNT MC# 61 Dalbavancin 61 phase IIb clinical 61 BENLYSTA ® 61 Fast Track Status 61 Genasense 61 investigational drug 61 Ridaforolimus 61 Positive Opinion 61 Cancidas 61 Orazol 61 Panzem 61 Ocrelizumab 61 Vfend 61 Xyotax 61 Orphan Drug Designation 61 Azacitidine 61 RSR# 61 panitumumab Vectibix 61 Traficet EN 61 Telzir 61 Nuvion 61 metastatic hormone refractory 61 Catena ® 61 topical NSAID 61 Clolar ® 60 Femara letrozole 60 Avanafil 60 ABRAXANE ® 60 Vernakalant 60 EFAPROXYN 60 TYKERB 60 Muraglitazar 60 tocilizumab 60 generation purine nucleoside 60 Orphan Drug status 60 Bevacizumab Avastin 60 AstraZeneca Iressa 60 ATL# [001] 60 #D#C# 60 Roche Actemra 60 Nebido 60 Panitumumab 60 octreotide implant 60 Plicera 60 forodesine 60 Orphan Status 60 docetaxel Taxotere 60 Preotact 60 Azathioprine 60 KRN# 60 Evoltra TM 60 Rebetol 60 Xcytrin 60 Camptosar 60 SYCREST 60 Telcyta 60 Tykerb 60 JAK Inhibitor 60 etanercept Enbrel 60 Zensana 60 cetuximab Erbitux 60 Revlimid lenalidomide 60 indacaterol 60 IMA# 60 Receives Positive Opinion 60 enzastaurin 60 Crizotinib 60 relapsed ovarian cancer 60 MOZOBIL 60 pazopanib 60 Abiraterone acetate 60 ELND# 60 Proxinium TM 60 Extavia 60 Navelbine ® 60 febuxostat 60 ProLindac 60 Genasense ® 60 Vertex telaprevir 60 Abbott Humira 60 Nimotuzumab 60 Desmoteplase 60 Onyx Pharma 60 biologic therapy 60 Hsp# Inhibitor 60 Modrenal R 60 investigational monoclonal antibody 60 rNAPc2 60 MGCD# [001] 60 pirfenidone 60 Orphan Drug designation 60 Lialda 60 Yervoy 60 Troxatyl TM 60 thymalfasin 60 Pafuramidine 60 Ciclesonide 60 Maraviroc 60 clofarabine 60 Azilect ® 60 seliciclib CYC# 60 Denosumab 60 OPAXIO TM 60 HuMax EGFr 60 Vicriviroc 60 pomalidomide 60 Urocidin 60 PDE4 inhibitor 60 Lung Cancer Drug 60 Vpriv 60 Rituxan rituximab 60 Annamycin 60 atrasentan 60 huC# DM4 60 Paliperidone Palmitate 60 PROVENGE ® 60 BARACLUDE R 60 HuMax CD# 60 abiraterone acetate 60 Tracleer r 60 YERVOY 60 Azixa 60 cinacalcet HCl 60 Vidaza R 60 posaconazole 60 Apixaban 60 Tezampanel 60 Theratope 60 Phase III Trials 60 Eltrombopag 60 vismodegib 60 Afinitor ® 60 Removab 60 SUTENT ® 60 Trobalt 60 Alitretinoin 60 Ranexa 60 Dificid 60 trabectedin 60 Eloxatin ® 60 ipilimumab 60 Tavocept 60 Xcytrin R 60 LymphoStat B belimumab 60 Acapodene 60 gastrointestinal stromal tumors 60 Eculizumab 60 Naglazyme 60 Gleevec Glivec 60 Velcade 60 anti EGFR antibody 60 ridaforolimus 60 VIDAZA 60 Pralatrexate 60 Ixabepilone 60 Betaferon ® 60 rilonacept 60 pralatrexate 60 fingolimod 60 ospemifene 60 PROMACTA 60 Betaferon 60 cladribine 60 cetuximab Erbitux R 60 MyVax R 60 Celebrex celecoxib 60 Frova ® 60 INSPIRE Trial Phase III 60 GLPG# 59 Orphan Designation 59 TELCYTA 59 Aliskiren 59 BiovaxID TM 59 Æterna Zentaris 59 EndoTAG TM -1 59 PLK1 SNALP 59 Genentech Rituxan 59 EOquin 59 Diamyd ® 59 TAXOTERE ® 59 Onalta ™ 59 Tesetaxel 59 IMiDs ® compound 59 Saxagliptin 59 vascular disrupting agent 59 Cabazitaxel 59 Trabectedin 59 TBC# 59 Indaflex TM 59 Orphan Drug designations 59 rasagiline tablets 59 telbivudine 59 acyclovir Lauriad R 59 Aryplase 59 Tyverb 59 Sutent 59 Imprime PGG 59 anticancer compound 59 Orphan Drug Status 59 HDAC Inhibitor 59 Onsolis 59 ZADAXIN ® 59 ELIQUIS 59 OMAPRO ™ 59 Belinostat 59 volociximab 59 Evoltra ® 59 Dyloject TM 59 custirsen 59 Carboplatin 59 refractory chronic lymphocytic 59 multi kinase inhibitor 59 pegylated interferons 59 Aplidin 59 DPP4 inhibitor 59 ponatinib 59 PD LID 59 imatinib Gleevec ® 59 KNS # 59 BCX# 59 Arcalyst 59 Asentar 59 Levoleucovorin 59 Loramyc 59 adalimumab Humira 59 DORIBAX 59 Lamivudine 59 Pixuvri 59 bazedoxifene 59 RoACTEMRA 59 PEG SN# 59 bendamustine 59 Fosrenol 59 Sensipar 59 Loramyc R 59 Pertuzumab 59 Allovectin 7 ® 59 chemotherapy cisplatin 59 Tanespimycin 59 Elagolix 59 Vidaza 59 Amevive 59 tesmilifene 59 Bydureon 59 Brilique 59 Zytiga 59 Bicifadine 59 lasofoxifene 59 lapatinib 59 Tolvaptan 59 Cimzia TM 59 Personalized Immunotherapy 59 Naproxcinod 59 alvespimycin 59 AVE# 59 successfully commercialize Iluvien 59 romiplostim 59 nucleoside analogue 59 Sycrest 59 BRAF inhibitor 59 Marketing Authorization Application MAA 59 CONBRIZA 59 RANK Ligand inhibitor 59 Riquent 59 SinuNase TM 59 paclitaxel Taxol 59 Yondelis ® 59 ORENCIA R 59 sunitinib Sutent 59 Vilazodone 59 RhuDex ® 59 Virulizin 59 ERBITUX 59 metastatic colorectal cancer 59 Peramivir 59 ZEVALIN 59 Panzem R 59 TORISEL 59 Egrifta 59 Vidaza azacitidine 59 Albuferon 59 Arzerra ofatumumab 59 investigational antiplatelet agent 59 XGEVA 59 Lapatinib 59 Fludarabine 59 Rilonacept 59 Tracleer R 59 targeted radiotherapeutic 59 Krystexxa 59 StaphVAX 59 Novartis Zometa 59 Xyrem ® 59 antibody MAb 59 BRILINTA 59 ruxolitinib 59 Tracleer 59 Bonefos 59 FOLOTYN 59 neratinib 59 Aviptadil 59 Amigal 59 Clinical Trial Results 59 ZEVALIN ® 59 PANVAC VF 59 Tesmilifene 59 Cimzia ® 59 SCCHN 59 Phase III Clinical Trial 59 bosutinib 59 Increlex R 59 EOquin TM 59 bevacizumab Avastin ® 59 Alvesco R 59 mRCC 59 atacicept 59 Pegloticase 59 Seliciclib 59 Telatinib 59 squamous non 59 Bezielle 59 virus HCV protease inhibitor 59 fenofibric acid 59 PegIntron 59 Orapred ODT 59 Somatuline Depot 59 Alvesco 59 maribavir 59 Cisplatin 59 receptor tyrosine kinase inhibitor 59 QAB# 59 Nitazoxanide 59 LHRH antagonist 59 bortezomib Velcade 59 Completes Patient Enrollment 59 TELINTRA 59 microtubule inhibitor 59 Novantrone 59 Increlex ® 59 PrevOnco ™ 59 orally bioavailable 59 Cloretazine 59 REVLIMID 59 metastatic castrate resistant 59 VALSTAR 59 gefitinib Iressa 59 ISENTRESS 59 Syncria 59 Alimta 59 Onbrez Breezhaler 59 Aurexis 59 ATryn ® 59 investigational immunotherapy 59 SPRYCEL ® 59 trabedersen 59 JOULFERON 59 Taxol paclitaxel 59 Pimavanserin 59 fidaxomicin 59 Tyrima 59 Iressa gefitinib 59 Silodosin 59 ZK EPO 59 TheraCIM 59 CCR5 antagonist 59 Hycamtin ® 59 MORAb 59 Phase IIb Trial 59 TEMODAR 59 SEBIVO 59 Cubicin 59 Friedreich Ataxia FRDA 59 Uvidem 59 Motavizumab 59 PEG INTRON 59 methylnaltrexone bromide 59 Uplyso 59 FUSILEV ® 59 Nexavar tablets 59 registrational 58 Ofatumumab 58 Zenpep 58 PF # [002] 58 phase III isavuconazole 58 Agenerase 58 BARACLUDE ® 58 Amgen Vectibix 58 gemcitabine chemotherapy 58 Drug Candidate 58 Paraplatin ® 58 XL# [003] 58 metaglidasen 58 Raptiva R 58 baminercept 58 epothilones 58 PEGINTRON TM 58 PREOS 58 Trastuzumab 58 FDA Accepts 58 Tamsulosin 58 AEGR 58 Gilenia 58 angiogenesis inhibitor 58 Eliquis 58 AEG# 58 Leukine 58 Nuedexta 58 farletuzumab 58 VEGF inhibitor 58 HoFH 58 mipomersen 58 ocular formulation 58 cell lymphoma CTCL 58 pancreatic enzyme replacement 58 Japanese Encephalitis vaccine 58 L Annamycin 58 Azedra 58 Nabi HB Intravenous 58 Zelrix 58 Targretin capsules 58 Genentech Roche 58 Arixtra 58 Emselex 58 Atrasentan 58 MEPACT 58 Xgeva 58 IV APAP 58 evaluating tivozanib 58 FTY# fingolimod 58 Plenaxis R 58 liposomal formulation 58 ONCONASE 58 Cetuximab Erbitux 58 Fibrillex TM 58 Adalimumab 58 Ilaris 58 Cimzia certolizumab pegol 58 Besivance 58 Virulizin ® 58 Abiraterone 58 PXD# 58 ThermoDox ® 58 Ceplene R 58 HGS ETR1 58 severe hypercholesterolemia 58 regadenoson 58 alvimopan 58 RP# [002] 58 pradefovir 58 GTC recombinant human 58 CLARITY study 58 IMC A# 58 Unit Dose Budesonide 58 IMiDs ® 58 Pfizer maraviroc 58 Tykerb lapatinib 58 mesylate 58 CYC# 58 Omacetaxine 58 Aptivus ® 58 Ozarelix 58 relapsed multiple myeloma 58 Liraglutide 58 Orphan Medicinal Product 58 Topotecan 58 Afatinib 58 ACOMPLIA R 58 Epivir 58 Combination REOLYSIN R 58 DEB# 58 Aphthasol R 58 Xyzal 58 Investigational Treatment 58 Eligard 58 Fludara 58 HER2 positive metastatic breast 58 entinostat 58 lumiliximab 58 lurasidone 58 BYETTA ® 58 Gleevec imatinib 58 Serdolect ® 58 ozarelix 58 albinterferon alfa 2b 58 nab paclitaxel 58 Soliris TM eculizumab 58 dirucotide 58 standard chemotherapy regimen 58 Omapro 58 RELOVAIR ™ 58 Hormone Refractory Prostate Cancer 58 dalbavancin 58 REVLIMID R 58 Arimidex anastrozole 58 IV Busulfex 58 dasatinib 58 rheumatoid arthritis psoriatic arthritis 58 Long Term Efficacy 58 BEMA TM Fentanyl 58 Talabostat 58 Exemestane 58 Faropenem 58 HFA MDI 58 LIALDA 58 Belimumab 58 Pennsaid R 58 immunotherapeutic agent 58 XL# XL# 58 Paraplatin ® carboplatin 58 lapatinib Tykerb 58 Phase 2b Clinical Trial 58 Emezine 58 pertuzumab 58 ONSOLIS 58 SUTENT 58 paclitaxel Taxol ® 58 midstage clinical 58 Taxotere 58 Rituxan 58 Fulvestrant 58 Ziopharm 58 Amplimexon 58 incyclinide 58 vidofludimus 58 Certriad 58 Bremelanotide 58 Tesamorelin 58 Receives Orphan Drug Designation 58 Dabigatran etexilate 58 Tygacil 58 MKC# MT 58 refractory metastatic 58 compound INCB# 58 Cloretazine ® 58 BrachySil 58 oral fludarabine 58 refractory multiple myeloma 58 Saforis 58 torezolid phosphate 58 ketolide antibiotic 58 Tofacitinib 58 Rasagiline 58 Zavesca r 58 cilengitide 58 Thalomid 58 fluoropyrimidine 58 Darusentan 58 fostamatinib 58 refractory metastatic colorectal cancer 58 XYOTAX TM 58 ceftaroline 58 refractory APL 58 PREOS R 58 octreotide acetate 58 DAVANAT R 58 Peginterferon 58 Prestara 58 IMiD 58 Pirespa 58 Olaparib 58 EGFR TKI 58 TYGACIL 58 FOLFIRI 58 INCB# [002] 58 MAA submission 58 cangrelor 58 BRIM2 58 Granted Orphan Drug 58 PhosLo 58 Genentech Herceptin 58 rituximab Rituxan 58 follicular Non Hodgkin 58 Lenocta 58 Eloxatin 58 Pradefovir 58 Rebif ® 58 telomerase therapeutic 58 Xeloda ® 58 Cellegesic 58 erlotinib Tarceva 58 CEQ# 58 Relistor 58 Anidulafungin 58 RoActemra 58 Rotarix ® 58 taxane chemotherapy 58 Galvus 58 LY# [003] 58 SEROQUEL XR 58 radiation sensitizer 58 Simponi golimumab 58 Simulect 58 Telbivudine 58 Rilutek 58 Pivotal Phase 58 trastuzumab DM1 T DM1 58 OncoVEX GM CSF 58 Renvela 58 Vertex hepatitis C 58 lintuzumab 58 Phase Ib II 58 Phase IIIb clinical 58 Campath alemtuzumab 58 Anastrozole 58 Omnitarg 58 ISTODAX 58 Octreolin 58 Adentri 58 THALOMID R 58 Advanced Renal Cell 58 phase IIb 57 Zingo TM 57 orBec 57 Avastin 57 Advagraf 57 cetuximab Erbitux ® 57 metastatic castration resistant 57 Plenaxis TM 57 Vidofludimus 57 ustekinumab 57 ProSavin 57 Entocort 57 Aclasta 57 dasatinib Sprycel ® 57 Sym# 57 TroVax ® 57 metastatic colorectal 57 motavizumab 57 Mircera 57 Sapacitabine 57 candidates Dyloject TM 57 TroVax 57 subcutaneous formulation 57 Tostrex 57 ocrelizumab 57 Gaucher Disease 57 FIRAZYR 57 Psoriasis Drug 57 Ceflatonin R 57 Actimmune R 57 Preotact R 57 brentuximab vedotin 57 Stimuvax 57 Allovectin 7 R 57 Aclasta Reclast 57 Actemra tocilizumab 57 palonosetron 57 Tocosol 57 INC# 57 vilazodone 57 Lupuzor 57 Phase III Clinical Trials 57 pediatric acute lymphoblastic 57 erlotinib Tarceva ® 57 zalutumumab 57 Tasigna 57 corticosteroid dexamethasone 57 sorafenib tosylate 57 abatacept 57 ZYBRESTAT 57 roflumilast 57 Zerenex 57 ZEGERID Capsules 57 MERREM 57 Dupuytren Contracture 57 INTELENCE 57 Toctino ® alitretinoin 57 afatinib 57 MEK inhibitors 57 Caelyx 57 MBP# [001] 57 Riluzole 57 Mitoxantrone 57 TAXOTERE R 57 Darinaparsin 57 orphan medicinal product 57 Xeloda capecitabine 57 CIMZIA TM 57 Ferumoxytol 57 Regeneron Pharma 57 Velaglucerase Alfa 57 Spectrum Pharmaceuticals 57 Entecavir 57 hoFH 57 Adventrx 57 Oracea ® 57 platinum refractory 57 Iloperidone 57 Apaziquone 57 Chronic Lymphocytic Leukemia 57 Brentuximab Vedotin SGN 57 BZL# 57 cutaneous T cell 57 oral methylnaltrexone 57 Relovair 57 ularitide 57 Radezolid 57 SERMs 57 Hedgehog Pathway Inhibitor 57 Ticagrelor 57 antiplatelet agent 57 vinca alkaloid 57 pemetrexed Alimta 57 Joulferon 57 docetaxel chemotherapy 57 goserelin 57 PSMA ADC 57 voclosporin 57 Flutiform 57 Ethyol 57 Newly Diagnosed Multiple Myeloma 57 CytoFab 57 Hematological Malignancies 57 CHOP chemotherapy 57 Linaclotide 57 Oracea TM 57 tamibarotene 57 Fablyn 57 Increlex 57 Novartis Gleevec 57 Junovan TM 57 sorafenib